BioSante Pharmaceuticals, Inc. Presents Phase III Bio-E-Gel(TM) Data At The International Society For The Study Of Women’s Sexual Health Annual Meeting

LINCOLNSHIRE, Ill.--(BUSINESS WIRE)--March 10, 2006--BioSante Pharmaceuticals, Inc. (Amex:BPA) announced the Company presented Bio-E-Gel data in an oral podium presentation at the International Society for the Study of Women’s Sexual Health (ISSWSH) Annual Meeting today. The ISSWSH meeting is being held from March 9-11, 2006 in Lisbon, Portugal. The presentation was entitled, “Bio-E-Gel(TM), A Transdermal Estradiol Gel, Effectively Treats Postmenopausal Vasomotor Symptoms.”